SilkMed is developing a patented sprayable silk-based wound dressing designed to improve burn care and support regenerative healing.
SilkMed has raised $250K in total funding. The most recent round was Non-equity Assistance. The last funding was announced in June 2026.
SilkMed's investors include Auxilium-MBI Accelerator.
SilkMed is headquartered in Cambridge, United States.
SilkMed is developing a patented sprayable silk-based wound dressing designed to improve burn care and support regenerative healing.
SilkMed is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SilkMed — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/silkmed. Accessed August 14, 2026.
VCBacked. (2026). SilkMed — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/silkmed
{{cite web |title=SilkMed — Funding & Investors |url=https://www.vcbacked.co/company/silkmed |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated